Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (331-340 of 13,978) with videos related to

Pageof 1,398
Sort By:
Leukemia|August 27, 2011
(+)α-Tocopheryl succinate inhibits the mitochondrial respiratory chain complex I and is as effective as arsenic trioxide or ATRA against acute promyelocytic leukemia in vivoG A S dos Santos, R S Abreu e Lima, C R Pestana, et al.
Leukemia|September 1, 1990
Chronic myeloid leukemia arising in a progenitor common to T cells and myeloid cellsA C Schuh, D R Sutherland, W Horsfall, et al.
Leukemia|June 22, 2011
SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignanciesS Hart, K C Goh, V Novotny-Diermayr, et al.
Leukemia|June 22, 2011
Primary myelofibrosis with or without mutant MPL: comparison of survival and clinical features involving 603 patientsA Pardanani, P Guglielmelli, T L Lasho, et al.
Leukemia|July 13, 2011
Impact of lenalidomide dose on progression-free survival in patients with relapsed or refractory multiple myelomaM A Dimopoulos, M Hussein, A S Swern, et al.
Leukemia|September 3, 2011
Action of novel CD37 antibodies on chronic lymphocytic leukemia cellsG Krause, M Patz, P Isaeva, et al.
Leukemia|June 1, 1990
A novel variant of the bcr-abl fusion product in Philadelphia chromosome-positive acute lymphoblastic leukemiaD Soekarman, J van Denderen, L Hoefsloot, et al.
Leukemia|September 3, 2011
Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trialU Platzbecker, M Wermke, J Radke, et al.
Leukemia|July 6, 2011
Bone marrow stem cell mobilization in stroke: a 'bonehead' may be good after all!C V Borlongan
Leukemia|August 20, 2011
Monoclonal antibody-based therapy as a new treatment strategy in multiple myelomaN W C J van de Donk, S Kamps, T Mutis, et al.
Pageof 1,398

Showing results (331-340 of 13,978) with videos related to

Sort By:
Pageof 1,398
Leukemia|August 27, 2011
(+)α-Tocopheryl succinate inhibits the mitochondrial respiratory chain complex I and is as effective as arsenic trioxide or ATRA against acute promyelocytic leukemia in vivoG A S dos Santos, R S Abreu e Lima, C R Pestana, et al.
Leukemia|September 1, 1990
Chronic myeloid leukemia arising in a progenitor common to T cells and myeloid cellsA C Schuh, D R Sutherland, W Horsfall, et al.
Leukemia|June 22, 2011
SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignanciesS Hart, K C Goh, V Novotny-Diermayr, et al.
Leukemia|June 22, 2011
Primary myelofibrosis with or without mutant MPL: comparison of survival and clinical features involving 603 patientsA Pardanani, P Guglielmelli, T L Lasho, et al.
Leukemia|July 13, 2011
Impact of lenalidomide dose on progression-free survival in patients with relapsed or refractory multiple myelomaM A Dimopoulos, M Hussein, A S Swern, et al.
Leukemia|September 3, 2011
Action of novel CD37 antibodies on chronic lymphocytic leukemia cellsG Krause, M Patz, P Isaeva, et al.
Leukemia|June 1, 1990
A novel variant of the bcr-abl fusion product in Philadelphia chromosome-positive acute lymphoblastic leukemiaD Soekarman, J van Denderen, L Hoefsloot, et al.
Leukemia|September 3, 2011
Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trialU Platzbecker, M Wermke, J Radke, et al.
Leukemia|July 6, 2011
Bone marrow stem cell mobilization in stroke: a 'bonehead' may be good after all!C V Borlongan
Leukemia|August 20, 2011
Monoclonal antibody-based therapy as a new treatment strategy in multiple myelomaN W C J van de Donk, S Kamps, T Mutis, et al.
Pageof 1,398